LEVOTHROID Side Effects

7029521-2 | Dysphagia, Gastritis, Hypothyroidism, Oesophageal Spasm
on Sep 27, 2010 Female patient from UNITED STATES , 67 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, gastritis, hypothyroidism, oesophageal spasm. Levothroid dosage: 50 Mcg (50 Mcg, 1 In 1 D), Oral. During the same period patient was treated with CITRACAL (CALCIUM CITRATE) (CALCIUM CITRATE) (View Citracal (calcium Citrate) (calcium Citrate) Review and Citracal (calcium Citrate) (calcium Citrate) Label ).

7018444-0 | Condition Aggravated, Dysphagia, Hypothyroidism, Oesophageal Disorder
Patient was taking Levothroid (View Usage). Patient had the following side effects: condition aggravated, dysphagia, hypothyroidism, oesophageal disorder on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with hypothyroidism and. Levothroid dosage: 50 Mcg (50 Mcg, 1 In 1 D), Oral. During the same period patient was treated with CITRACAL (CALCIUM CITRATE) (View Citracal (calcium Citrate) Review and Citracal (calcium Citrate) Label ).

6773920-0 | Product Substitution Issue, Swelling
Adverse event was reported on Jun 16, 2010 by a Female patient taking Levothroid (View Usage) (Dosage: 75 Mcg 1 A Day) was diagnosed with hypothyroidism and. Location: UNITED STATES , weighting 130.0 lb, After Levothroid was administered, patient had the following side effects: product substitution issue, swelling.

6730531-0 | Acute Myocardial Infarction, Bundle Branch Block Left, Conjunctival Oedema, Diplopia, Endocrine Ophthalmopathy, Exophthalmos, Eyelid Oedema, Swelling
on May 03, 2010 Female patient from DENMARK , 76 years of age, was diagnosed with hypothyroidism, endocrine ophthalmopathy and was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, bundle branch block left, conjunctival oedema, diplopia, endocrine ophthalmopathy, exophthalmos, eyelid oedema, swelling. Levothroid dosage: . During the same period patient was treated with METHYLPREDNISOLONE (1 Gm (1gm, 1 In 1d), Intravenous) (View Methylprednisolone Review and Methylprednisolone Label ).


6678096-6 | Dry Skin, Product Substitution Issue, Pruritus, Rash
on Apr 09, 2010 Female patient from UNITED STATES , 87 years of age, weighting 138.0 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient had the following side effects: dry skin, product substitution issue, pruritus, rash (What is rash?). Levothroid dosage: One Daily Po.

6667297-9 | Abdominal Pain, Blood Cholesterol Increased, Cholelithiasis, Hepatic Enzyme Increased
Patient was taking Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood cholesterol increased, cholelithiasis, hepatic enzyme increased on Mar 26, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with hypothyroidism and. Levothroid dosage: 100 Mcg (100 Mcg, 1 In 1 D), Oral.

6656835-8 | Dehydration, Fall, Feeling Cold
Adverse event was reported on Mar 19, 2010 by a Female patient taking Levothroid (View Usage) (Dosage: 100 Mcg (100 Mcg, 1 In 1 D), Oral) was diagnosed with hypothyroidism and. Location: UNITED STATES , 77 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, fall (What is fall?), feeling cold. During the same period patient was treated with ACETAMINOPHEN PM (View Acetaminophen Pm Review and Acetaminophen Pm Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ). Patient was hospitalized.

6557217-X | Pruritus
on Jan 27, 2010 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with autoimmune thyroiditis, hypothyroidism and was treated with Levothroid (View Usage). Patient had the following side effects: pruritus. Levothroid dosage: 1 Tab Daily Po.

6526702-9 | Hyperaesthesia, Infection, Scar
on Jan 04, 2010 Female patient from UNITED STATES , 79 years of age, weighting 200.0 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: hyperaesthesia, infection (What is infection?), scar (What is scar?). Levothroid dosage: 1 1/2 Tab Daily Oral.

6355592-2 | Heart Rate Increased
Patient was taking Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased on Sep 08, 2009 from UNITED STATES Additional patient health information: Female patient , 45 years of age, was diagnosed with hypothyroidism and. Levothroid dosage: 25 Mcg (25 Mcg, 1 In 1 D), Oral. Patient was hospitalized.

6337550-7 | Abdominal Discomfort, Abdominal Distension, Fatigue, Impaired Driving Ability, Somnolence
Adverse event was reported on Sep 01, 2009 by a Female patient taking Levothroid (View Usage) (Dosage: 88 Mcg Daily Po) was diagnosed with hypothyroidism and. Location: UNITED STATES , weighting 131.0 lb, Patient had the following side effects: abdominal discomfort, abdominal distension, fatigue, impaired driving ability, somnolence.

6243839-2 | Dizziness, Fatigue, Palpitations, Transient Ischaemic Attack
on Jun 18, 2009 Female patient from UNITED STATES , 69 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, palpitations, transient ischaemic attack. Levothroid dosage: 75 Mcg (75 Mcg, 1 In 1 D), Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6222548-X | Product Quality Issue
on Jun 09, 2009 Female patient from UNITED STATES , 61 years of age, weighting 202.0 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue. Levothroid dosage: 1x Per Day Po.

6161331-0 | Alopecia, Dry Skin, Feeling Cold, Hypothyroidism, Incorrect Dose Administered, Product Colour Issue
Patient was taking Levothroid (View Usage). Patient had the following side effects: alopecia, dry skin, feeling cold, hypothyroidism, incorrect dose administered, product colour issue on Apr 17, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with thyroidectomy and. Levothroid dosage: 1 Tablet Daily Po.

6145140-4 | Blood Pressure Increased, Marital Problem, Product Contamination
Adverse event was reported on Apr 02, 2009 by a Female patient taking Levothroid (View Usage) (Dosage: 125 Mcg Qam Po) . Location: UNITED STATES , 61 years of age, After Levothroid was administered, patient had the following side effects: blood pressure increased, marital problem, product contamination.

6103622-5 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Feb 12, 2009 Male patient from UNITED STATES , 59 years of age, was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Levothroid dosage: Oral. During the same period patient was treated with ATENOLOL (Oral) (View Atenolol Review and Atenolol Label ), DESIPRAMINE HCL (Oral) (View Desipramine Hcl Review and Desipramine Hcl Label ), SALSALATE (Oral) (View Salsalate Review and Salsalate Label ), NALTREXONE HYDROCHLORIDE (Oral) (View Naltrexone Hydrochloride Review and Naltrexone Hydrochloride Label ), TRAZODONE HCL (Oral) (View Trazodone Hcl Review and Trazodone Hcl Label ), ETHANOL (Oral) (View Ethanol Review and Ethanol Label ).

6103287-2 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Feb 12, 2009 Male patient from UNITED STATES , 37 years of age, was treated with Levothroid (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Levothroid dosage: Oral. During the same period patient was treated with BUPROPION HCL (Oral) (View Bupropion Hcl Review and Bupropion Hcl Label ), QUETIAPINE FUMARATE (Oral) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), BACLOFEN (Oral) (View Baclofen Review and Baclofen Label ), PROMETHAZINE (Oral) (View Promethazine Review and Promethazine Label ), METHADONE HCL (Oral) (View Methadone Hcl Review and Methadone Hcl Label ), DULOXETINE HYDROCHLORIDE (Oral) (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), CLONAZEPAM (Oral) (View Clonazepam Review and Clonazepam Label ), ZOLPIDEM (Oral) (View Zolpidem Review and Zolpidem Label ).

6103286-0 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Patient was taking Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest on Feb 12, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Levothroid dosage: Oral. During the same period patient was treated with ACETAMINOPHEN / DIPHENHYDRAMINE (Oral) (View Acetaminophen / Diphenhydramine Review and Acetaminophen / Diphenhydramine Label ), CLONAZEPAM (Oral) (View Clonazepam Review and Clonazepam Label ), DULOXETINE HYDROCHLORIDE (Oral) (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ).

6103194-5 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Adverse event was reported on Feb 12, 2009 by a Male patient taking Levothroid (View Usage) (Dosage: Oral) . Location: UNITED STATES , 85 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. During the same period patient was treated with PAROXETINE HCL (Oral) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), TERAZOSIN HCL (Oral) (View Terazosin Hcl Review and Terazosin Hcl Label ).

6103185-4 | Completed Suicide
on Feb 12, 2009 Female patient from UNITED STATES , 47 years of age, was treated with Levothroid (View Usage). Patient had the following side effects: completed suicide. Levothroid dosage: Oral. During the same period patient was treated with QUETIAPINE FUMARATE (Oral) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), MIRTAZAPINE (Oral) (View Mirtazapine Review and Mirtazapine Label ), TRAZODONE HCL (Oral) (View Trazodone Hcl Review and Trazodone Hcl Label ), GABAPENTIN (Oral) (View Gabapentin Review and Gabapentin Label ), TOPIRAMATE (Oral) (View Topiramate Review and Topiramate Label ), HYDROXYZINE (Oral) (View Hydroxyzine Review and Hydroxyzine Label ), EZETIMIBE (Oral) (View Ezetimibe Review and Ezetimibe Label ).

5887791-8 | Heart Rate Irregular, Tachycardia
on Sep 17, 2008 Female patient from UNITED STATES , 60 years of age, weighting 141.0 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: heart rate irregular, tachycardia. Levothroid dosage: 1 Daily Po.

5847602-3 | Heart Rate Increased, Heart Rate Irregular, Palpitations
Patient was taking Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased, heart rate irregular, palpitations on Aug 15, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 129.0 lb, was diagnosed with blood thyroid stimulating hormone decreased and. Levothroid dosage: 50mcg One Qd Po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5835338-4 | Anxiety, Atrial Fibrillation, Blood Pressure Increased, Cardiac Failure, Dilatation Ventricular, Fatigue, Muscular Weakness, Nausea, Weight Increased
Adverse event was reported on Jul 30, 2008 by a Male patient taking Levothroid (View Usage) (Dosage: 100 Mcg (100 Mcg, 1 In 1 D), Oral) was diagnosed with autoimmune thyroiditis, goitre and. Location: UNITED STATES , 67 years of age, weighting 220.0 lb, Patient had the following side effects: anxiety (What is anxiety?), atrial fibrillation (What is atrial fibrillation?), blood pressure increased, cardiac failure, dilatation ventricular, fatigue, muscular weakness, nausea (What is nausea?), weight increased. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), PROTONIX (View Protonix Review and Protonix Label ), VITAMINS (NOS) (View Vitamins (nos) Review and Vitamins (nos) Label ).

5827996-5 | Atrial Fibrillation, Blood Pressure Increased, Cardiac Failure, Dilatation Ventricular, Irritability, Nausea, Weight Increased
on Jul 18, 2008 Male patient from UNITED STATES , 67 years of age, weighting 220.0 lb, was diagnosed with autoimmune thyroiditis, goitre and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood pressure increased, cardiac failure, dilatation ventricular, irritability, nausea (What is nausea?), weight increased. Levothroid dosage: 100 Mcg (100 Mcg, 1 In 1 D), Oral. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), PROTONIX (View Protonix Review and Protonix Label ), VITAMINS (NOS) (View Vitamins (nos) Review and Vitamins (nos) Label ).

5777156-1 | Anxiety, Blood Pressure Increased, Heart Rate Increased
on Jun 17, 2008 Female patient from UNITED STATES , 60 years of age, weighting 135.0 lb, was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood pressure increased, heart rate increased. Levothroid dosage: .

5680609-8 | Agitation, Contusion, Fall, Haemorrhage, Rib Fracture, Somnambulism
Patient was taking Levothroid (View Usage). Patient had the following side effects: agitation, contusion, fall (What is fall?), haemorrhage, rib fracture, somnambulism on Mar 14, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 172.0 lb, was diagnosed with insomnia, osteoporosis (What is osteoporosis?), gout (What is gout?) and. Levothroid dosage: Unk. During the same period patient was treated with AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMILORIDE HYDROCHLORIDE (View Amiloride Hydrochloride Review and Amiloride Hydrochloride Label ), THYROID TAB (Unk) (View Thyroid Tab Review and Thyroid Tab Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CALCIUM W/ VITAMIN D (View Calcium W/ Vitamin D Review and Calcium W/ Vitamin D Label ), COLCHICINE (View Colchicine Review and Colchicine Label ).

5628340-9 | Agitation, Contusion, Fall, Haemorrhage, Rib Fracture, Somnambulism
Adverse event was reported on Feb 05, 2008 by a Female patient taking Levothroid (View Usage) (Dosage: Unk) was diagnosed with insomnia and. Location: UNITED STATES , weighting 172.0 lb, After Levothroid was administered, patient had the following side effects: agitation, contusion, fall (What is fall?), haemorrhage, rib fracture, somnambulism. During the same period patient was treated with AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMILORIDE HYDROCHLORIDE (View Amiloride Hydrochloride Review and Amiloride Hydrochloride Label ).

5607610-4 | Asthenia, Blood Thyroid Stimulating Hormone Increased, Nausea, Palpitations
on Jan 28, 2008 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood thyroid stimulating hormone increased, nausea (What is nausea?), palpitations. Levothroid dosage: One Tablet Daily Po. Patient was hospitalized.

5442531-1 | Blood Thyroid Stimulating Hormone Decreased, Hepatic Steatosis
on Aug 23, 2007 Female patient from UNITED STATES , 39 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient had the following side effects: blood thyroid stimulating hormone decreased, hepatic steatosis. Levothroid dosage: 112 Mcg Qd Po.

5398604-5 | Blood Thyroid Stimulating Hormone Decreased, Hepatic Steatosis
Patient was taking Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: blood thyroid stimulating hormone decreased, hepatic steatosis on Jul 10, 2007 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with hypothyroidism and. Levothroid dosage: 112 Mcg Qd; Po.

5226362-3 | Alopecia, Dry Skin, Fatigue, Gastrooesophageal Reflux Disease, Weight Increased
Adverse event was reported on Jan 23, 2007 by a Female patient taking Levothroid (View Usage) (Dosage: 125 Mcg Qd Po) was diagnosed with hypothyroidism and. Location: UNITED STATES , 68 years of age, weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: alopecia, dry skin, fatigue, gastrooesophageal reflux disease, weight increased.

5195934-7 | Heart Rate Increased
on Dec 15, 2006 Female patient from UNITED STATES , 54 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient had the following side effects: heart rate increased. Levothroid dosage: 137 Mcg Qd Po. During the same period patient was treated with CYTOMEL (View Cytomel Review and Cytomel Label ), NEXIUM (View Nexium Review and Nexium Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

5193673-X | Heart Rate Increased
on Dec 15, 2006 Female patient from UNITED STATES , 54 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: heart rate increased. Levothroid dosage: 137 Mcg Qd Po. During the same period patient was treated with CYTOMEL (View Cytomel Review and Cytomel Label ), NEXIUM (View Nexium Review and Nexium Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

5147391-4 | Alopecia, Chest Pain, Dry Skin, Fatigue, Gastrooesophageal Reflux Disease, Weight Fluctuation
Patient was taking Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, chest pain (What is chest pain?), dry skin, fatigue, gastrooesophageal reflux disease, weight fluctuation on Oct 31, 2006 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 180.0 lb, was diagnosed with hypothyroidism and. Levothroid dosage: 125 Mcg Qd Po.

5102062-5 | Alopecia, Chest Pain, Dry Skin, Fatigue, Gastrooesophageal Reflux Disease, Weight Increased
Adverse event was reported on Sep 05, 2006 by a Female patient taking Levothroid (View Usage) (Dosage: 125 Mcg Qd Po) was diagnosed with hypothyroidism and. Location: UNITED STATES , 68 years of age, weighting 180.0 lb, Patient had the following side effects: alopecia, chest pain (What is chest pain?), dry skin, fatigue, gastrooesophageal reflux disease, weight increased.

5081586-3 | Chest Pain, Gastrooesophageal Reflux Disease, Weight Increased
on Jul 31, 2006 Female patient from UNITED STATES , 68 years of age, weighting 188.0 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: chest pain (What is chest pain?), gastrooesophageal reflux disease, weight increased. Levothroid dosage: 125 Mcg Qd Po.

5027315-0 | Blood Thyroid Stimulating Hormone Abnormal, Blood Thyroid Stimulating Hormone Increased, Condition Aggravated, Depression, Fatigue, Hypersomnia
on Jun 02, 2006 Female patient from UNITED STATES , 57 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: blood thyroid stimulating hormone abnormal, blood thyroid stimulating hormone increased, condition aggravated, depression (What is depression?), fatigue, hypersomnia. Levothroid dosage: 300 Mcg Qd Po. During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ENBREL (View Enbrel Review and Enbrel Label ), MEPHOBARBITAL (View Mephobarbital Review and Mephobarbital Label ).

4958326-9 | Eye Disorder, Strabismus, Thyroid Function Test Abnormal, Thyroiditis
Patient was taking Levothroid (View Usage). Patient had the following side effects: eye disorder, strabismus, thyroid function test abnormal, thyroiditis on Mar 29, 2006 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 210.0 lb, . Levothroid dosage: 1 Pill Daily Po. Patient was hospitalized.

4941896-4 | Hypersensitivity, Pharyngeal Oedema, Urinary Tract Infection
Adverse event was reported on Feb 28, 2006 by a Female patient taking Levothroid (View Usage) (Dosage: 50 Mcg Qd Po) was diagnosed with hypothyroidism, urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 45 years of age, After Levothroid was administered, patient had the following side effects: hypersensitivity, pharyngeal oedema, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), XANAX (View Xanax Review and Xanax Label ), ADVIL (View Advil Review and Advil Label ).

4941895-2 | Dehydration, Renal Failure Acute
on Mar 01, 2006 Male patient from UNITED STATES , 62 years of age, was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, renal failure acute. Levothroid dosage: . Patient was hospitalized.

4938999-7 | Toxic Epidermal Necrolysis
on Mar 01, 2006 Female patient from UNITED STATES , 80 years of age, was treated with Levothroid (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Levothroid dosage: . During the same period patient was treated with DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), INSULIN (View Insulin Review and Insulin Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), LASIX (View Lasix Review and Lasix Label ), AVANDIA (View Avandia Review and Avandia Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized and became disabled.

4901892-X | Anxiety
Patient was taking Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: anxiety (What is anxiety?) on Feb 02, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with hypothyroidism and. Levothroid dosage: .1mg 1 Per Day 7,8 Of 05. During the same period patient was treated with SYNTHROID (.1mg 1 Per Day 11,12, Of 05) (View Synthroid Review and Synthroid Label ).

4871959-3 | Dehydration, Renal Failure Acute
Adverse event was reported on Dec 20, 2005 by a Male patient taking Levothroid (View Usage) (Dosage: ) . Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, renal failure acute. Patient was hospitalized.

4815172-4 | Anxiety, Cerebrovascular Accident, Injury, Pain
on Oct 03, 2005 Female patient from UNITED STATES , 71 years of age, weighting 200.6 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Levothroid (View Usage). Patient had the following side effects: anxiety (What is anxiety?), cerebrovascular accident, injury, pain (What is pain?). Levothroid dosage: . During the same period patient was treated with VIOXX (View Vioxx Review and Vioxx Label ). Patient was hospitalized.

4749644-8 | Astrocytoma, Cardio-respiratory Arrest, Cerebrovascular Accident, Cerebrovascular Disorder, Confusional State, Coronary Artery Disease, Decreased Appetite, Dehydration, Disorientation
on Mar 10, 2005 Female patient from UNITED STATES , 79 years of age, weighting 149.9 lb, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: astrocytoma, cardio-respiratory arrest, cerebrovascular accident, cerebrovascular disorder, confusional state, coronary artery disease (What is coronary artery disease?), decreased appetite, dehydration, disorientation. Levothroid dosage: . During the same period patient was treated with VIOXX (View Vioxx Review and Vioxx Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

4716972-1 | Abdominal Distension, Diarrhoea
Patient was taking Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, diarrhoea on Jul 12, 2005 from UNITED STATES Additional patient health information: Female patient , 88 years of age, was diagnosed with hypothyroidism, prophylaxis and. Levothroid dosage: 112.5 Mcg Qd Po. During the same period patient was treated with NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ). Patient was hospitalized.

4694544-5 | Astrocytoma, Cardio-respiratory Arrest, Cerebrovascular Accident, Cerebrovascular Disorder, Coronary Artery Disease, Decreased Appetite, Dehydration, Dyspnoea, Hypercalcaemia
Adverse event was reported on Mar 10, 2005 by a Female patient taking Levothroid (View Usage) (Dosage: ) was diagnosed with hypothyroidism and. Location: , 80 years of age, weighting 149.9 lb, Patient had the following side effects: astrocytoma, cardio-respiratory arrest, cerebrovascular accident, cerebrovascular disorder, coronary artery disease (What is coronary artery disease?), decreased appetite, dehydration, dyspnoea, hypercalcaemia. During the same period patient was treated with VIOXX (View Vioxx Review and Vioxx Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

4688389-X | Alopecia, Fatigue
on Jun 10, 2005 Female patient from , weighting 200.0 lb, was treated with Levothroid (View Usage). After Levothroid was administered, patient had the following side effects: alopecia, fatigue. Levothroid dosage: 1 Po Qd.

4685947-3 | Abdominal Distension, Diarrhoea, Stomach Discomfort
on May 24, 2005 Female patient from , 88 years of age, was diagnosed with hypothyroidism and was treated with Levothroid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, diarrhoea, stomach discomfort. Levothroid dosage: 112.5 Mcg Qd Po. During the same period patient was treated with NITROFURANTOIN MACROCRYSTALLINE (View Nitrofurantoin Macrocrystalline Review and Nitrofurantoin Macrocrystalline Label ). Patient was hospitalized.

4658415-2 | Convulsion, Dyskinesia, Insomnia, Tremor
Patient was taking Levothroid (View Usage). Patient had the following side effects: convulsion, dyskinesia, insomnia, tremor on May 10, 2005 from Additional patient health information: Female patient , 32 years of age, weighting 187.0 lb, was diagnosed with hypothyroidism and. Levothroid dosage: 0.075 Tqd.